Dysregulation of the adipoinsular axis -- a mechanism for the pathogenesis of hyperleptinemia and adipogenic diabetes induced by fetal programming
- PMID: 11479129
- DOI: 10.1677/joe.0.1700323
Dysregulation of the adipoinsular axis -- a mechanism for the pathogenesis of hyperleptinemia and adipogenic diabetes induced by fetal programming
Abstract
Obesity and its related disorders are the most prevalent health problems in the Western world. Using the paradigm of fetal programming we developed a rodent model which displays the phenotype of obesity and metabolic disorders commonly observed in human populations. We apply maternal undernutrition throughout gestation, generating a nutrient-deprived intrauterine environment to induce fetal programming. Maternal undernutrition results in fetal growth retardation and in significantly decreased body weight at birth. Programmed offspring develop hyperphagia, obesity, hypertension, hyperleptinemia and hyperinsulinism during adult life and postnatal hypercaloric nutrition amplifies the metabolic abnormalities induced by fetal programming. The adipoinsular axis has been proposed as a primary candidate for linking the status of body fat mass to the function of the pancreatic beta-cells. We therefore investigated the relationship between circulating plasma concentrations of leptin and insulin and immunoreactivity in the endocrine pancreas for leptin and leptin receptor (OB-R) in genetically normal rats that were programmed to become obese during adult life. Virgin Wistar rats were time mated and randomly assigned to receive food either available ad libitum (AD group) or at 30% of the ad libitum available intake (UN group). Offspring from UN mothers were significantly smaller at birth than AD offspring (AD 6.13+/-0.04 g, UN 4.02+/-0.03 g, P<0.001). At weaning, offspring were assigned to one of two diets (a standard control diet or a hypercaloric diet consisting of 30% fat) for the remainder of the study. At the time of death (125 days of age), UN offspring had elevated (P<0.005) fasting plasma insulin (AD control 1.417+/-0.15 ng/ml, UN control 2.493+/-0.33 ng/ml, AD hypercaloric 1.70+/-0.17 ng/ml, UN hypercaloric 2.608+/-0.41 ng/ml) and leptin (AD control 8.8+/-1.6 ng/ml, UN control 14.32+/-1.9 ng/ml, AD hypercaloric 15.11+/-1.8 ng/ml, UN hypercaloric 30.18+/-5.3 ng/ml) concentrations, which were further increased (P<0.05) by postnatal hypercaloric nutrition. The elevated plasma insulin and leptin concentrations were paralleled by increased immunolabeling for leptin in the peripheral cells of the pancreatic islets. Dual immunofluorescence histochemistry for somatostatin and leptin revealed that leptin was co-localized in the pancreatic delta-cells. OB-R immunoreactivity was evenly distributed throughout the pancreatic islets and was not changed by programming nor hypercaloric nutrition. Our data suggest that reduced substrate supply during fetal development can trigger permanent dysregulation of the adipoinsular feedback system leading to hyperleptinemia, hyperinsulinism and compensatory leptin production by pancreatic delta-cells in a further attempt to reduce insulin hypersecretion in the progression to adipogenic diabetes.
Similar articles
-
Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition.Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E83-7. doi: 10.1152/ajpendo.2000.279.1.E83. Am J Physiol Endocrinol Metab. 2000. PMID: 10893326
-
IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming.Endocrinology. 2001 Sep;142(9):3964-73. doi: 10.1210/endo.142.9.8390. Endocrinology. 2001. PMID: 11517175
-
Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition.Am J Physiol Regul Integr Comp Physiol. 2003 Jul;285(1):R271-3. doi: 10.1152/ajpregu.00051.2003. Am J Physiol Regul Integr Comp Physiol. 2003. PMID: 12794001
-
The adipoinsular axis: effects of leptin on pancreatic beta-cells.Am J Physiol Endocrinol Metab. 2000 Jan;278(1):E1-E14. doi: 10.1152/ajpendo.2000.278.1.E1. Am J Physiol Endocrinol Metab. 2000. PMID: 10644531 Review.
-
Prenatal programming of postnatal obesity: fetal nutrition and the regulation of leptin synthesis and secretion before birth.Proc Nutr Soc. 2004 Aug;63(3):405-12. doi: 10.1079/pns2004370. Proc Nutr Soc. 2004. PMID: 15373950 Review.
Cited by
-
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas.World J Gastroenterol. 2023 Jul 14;29(26):4136-4155. doi: 10.3748/wjg.v29.i26.4136. World J Gastroenterol. 2023. PMID: 37475842 Free PMC article. Review.
-
Recent progress in epigenetics of obesity.Diabetol Metab Syndr. 2022 Nov 17;14(1):171. doi: 10.1186/s13098-022-00947-1. Diabetol Metab Syndr. 2022. PMID: 36397166 Free PMC article. Review.
-
Maternal Supplementation of Probiotics, Prebiotics or Postbiotics to Prevent Offspring Metabolic Syndrome: The Gap between Preclinical Results and Clinical Translation.Int J Mol Sci. 2022 Sep 5;23(17):10173. doi: 10.3390/ijms231710173. Int J Mol Sci. 2022. PMID: 36077575 Free PMC article. Review.
-
Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice.Front Pharmacol. 2022 Aug 15;13:973927. doi: 10.3389/fphar.2022.973927. eCollection 2022. Front Pharmacol. 2022. PMID: 36046814 Free PMC article.
-
Cardiometabolic Phenotypic Differences in Male Offspring Born to Obese Preeclamptic-Like BPH/5 Mice.Front Pediatr. 2021 Sep 22;9:636143. doi: 10.3389/fped.2021.636143. eCollection 2021. Front Pediatr. 2021. PMID: 34631607 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
